CVS Caremark
Sector: Consumer Staples
12-month Performance: +24.9%
Walgreens (NYSE:WAG) and CVS Caremark (NYSE:CVS) each get 100% of their revenue here in the U.S., but we had to give the nod to CVS for this portfolio.
Why? Well, the same reasons it got a spot in our Real America Index: CVS Caremark is the largest pharmacy healthcare provider in the U.S., the No. 1 provider of prescriptions and the No. 1 specialty pharmacy.
That kind of presence has paid off for investors too, as CVS has added nearly 25% to its value during the past 12 months, including an 8% gain so far this year. According to Standard & Poor’s, the company is estimated to grow earnings per share by 32% for FY2012, topped by growth of 17% in FY2013.
Tack on a decent 1.7% dividend, and it’s the perfect pick for our home-grown portfolio.
Comments are currently unavailable. Please check back soon.